Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 853,003
  • Shares Outstanding, K 62,263
  • Annual Sales, $ 1,430 K
  • Annual Income, $ -46,510 K
  • 60-Month Beta 1.46
  • Price/Sales 591.37
  • Price/Cash Flow N/A
  • Price/Book 3.48
Trade CATX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.21
  • Number of Estimates 2
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +47.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.36 +46.37%
on 06/27/24
14.09 -2.77%
on 07/26/24
+4.19 (+44.06%)
since 06/26/24
3-Month
8.16 +67.89%
on 06/26/24
19.05 -28.08%
on 05/15/24
-2.10 (-13.29%)
since 04/26/24
52-Week
2.05 +568.29%
on 09/15/23
19.05 -28.08%
on 05/15/24
+7.70 (+128.30%)
since 07/26/23

Most Recent Stories

More News
Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care

/PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a contract development and manufacturing organization and radiopharmaceutical...

CATX : 13.70 (+0.59%)

Business Summary

Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash....

See More

Key Turning Points

3rd Resistance Point 14.86
2nd Resistance Point 14.47
1st Resistance Point 14.09
Last Price 13.70
1st Support Level 13.32
2nd Support Level 12.93
3rd Support Level 12.55

See More

52-Week High 19.05
Last Price 13.70
Fibonacci 61.8% 12.56
Fibonacci 50% 10.55
Fibonacci 38.2% 8.54
52-Week Low 2.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar